Menu

Ancient Origins of Retroviruses

Foamy-like endogenous retroviruses may have emerged more than 450 million years ago, according to an analysis.

Jan 12, 2017
Tracy Vence

WIKIMEDIA, ZOO FIRMAFoamy-like endogenous retroviruses (FLERVs), which are found in fish and amphibian genomes, may have originated with their vertebrate hosts more than 450 million years ago, according to a study published in Nature Communications this week (January 10). Analyzing retroviral sequence data for FLERVs found in ray-finned fish genomes, Pakorn Aiewsakun and Aris Katzourakis of Oxford University in the U.K. traced two retroviral lineages back to the emergence of the vertebrates.

“These findings show that this medically important group of viruses is at least up to half a billion years in age—far older than previously thought,” Katzourakis said in a press release. “They date back to the origins of vertebrates, and this gives us the context in which we should consider their present-day activity and interactions with their hosts.”

 “We’re up against the limits of our ability to determine their age,” Michael Worobey of the University of Arizona, who was not involved in the work, told Nature.

Michael Emerman of the Fred Hutchinson Cancer Research Center in Seattle, who also was not involved in the work, told Nature that this analytical approach is applicable to animals other than fish. “Almost every animal has a retrovirus, and their evolution occurred with these viruses,” he said. “You can’t consider the evolution of a species without the evolution of their pathogens.”

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.